In vitro anti-sickling effect of cepharanthine

  • Sato T
  • Tsuyoshi Ohnishi S
  • 2


    Mendeley users who have this article in their library.
  • 15


    Citations of this article.


Cepharantine, a bisbenzylisoquinoline alkaloid, was found to have in vitro anti-sickling activity. The activity is of the same magnitude as that of chlorpromazine, an anti-psychotic drug, but cepharantine has no neuroleptic action. The most attractive feature of cepharanthine as a possible anti-sickling drug may be that the drug has been clinically used in Japan for other diseases and is known to have very few side effects both when given in large doses and over a long term. The drug can be administered either orally or intravenously. Cepharanthine has been reported to have several clinical effects, such as enhancement of the immune response, improvement of peripheral circulation, vasodilation and inhibition of platelet aggregation, all of which may also be beneficial to sickle-cell patients. © 1982.

Author-supplied keywords

  • Anti-sickling activity
  • Cepharanthine

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Takashi Sato

  • S. Tsuyoshi Ohnishi

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free